JULIA CAROLINE BABCOCK

Dr. JULIA CAROLINE BABCOCK

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2004 in Clinical Psychology Review
Verified
Journal Article
Closed access
JBJULIA CAROLINE BABCOCK
JULIA CAROLINE BABCOCK
CGCharles E Green
Charles E Green
CRChet Robie
Chet Robie

1 June 2003 in Psychology of Women Quarterly
Verified
Journal Article
Closed access
JBJULIA CAROLINE BABCOCK
JULIA CAROLINE BABCOCK
SMSarah A. Miller
Sarah A. Miller
CSCheryl Siard
Cheryl Siard


1 January 2011 in Journal of Gay & Lesbian Mental Health
Verified
Journal Article
Closed access
CAColt St. Amand
Colt St. Amand
KFKara M. Fitzgerald
Kara M. Fitzgerald
SPSeth T. Pardo
Seth T. Pardo
JBJULIA CAROLINE BABCOCK
JULIA CAROLINE BABCOCK
SMStacey L. Colton Meier Ma
Stacey L. Colton Meier Ma
Hormonal interventions are an often-sought option for transgender individuals seeking to medically transition to an authentic gender. Current literature stresses that the effects and associated risks of hormone regimens should be monitored and well understood by health care providers (Feldman & Bockting, 2003 Feldman, J. and Bockting, W. 2003. Transgender health. Minnesota Medicine, 86 [Google Scholar] ). However, the positive psychological effects following hormone replacement therapy as a gender affirming treatment have not been adequately researched. This study examined the relationship of hormone replacement therapy, specifically testosterone, with various mental health outcomes in an Internet sample of more than 400 self-identified female-to-male transsexuals. Results of the study indicate that female-to-male transsexuals who receive testosterone have lower levels of depression, anxiety, and stress, and higher levels of social support and health related quality of life. Testosterone use was not related to problems with drugs, alcohol, or suicidality. Overall findings provide clear evidence that HRT is associated with improved mental health outcomes in female-to-male transsexuals.

1 September 2004 in Journal of Family Psychology
Verified
Journal Article
Closed access
JBJULIA CAROLINE BABCOCK
JULIA CAROLINE BABCOCK
DCDaniela M. Costa
Daniela M. Costa
CGCharles E. Green
Charles E. Green
CEChristopher I. Eckhardt
Christopher I. Eckhardt
The current study investigated the reliability of a new self-report questionnaire assessing stimuli that would likely elicit intimate partner violence. The Proximal Antecedents to Violent Episodes (PAVE) scale is a 30-item, Likert-type measure designed to assess situations that would reportedly precede the use of violence. In Study 1, an exploratory factor analysis on a clinical sample revealed 3 factors: Violence to Control, Violence Out of Jealousy, and Violence Following Verbal Abuse. In Study 2, the factor structure was replicated on a community sample using confirmatory factor analysis. In both studies, different types of batterers, on the basis of A. Holtzworth-Munroe and G. L. Stuart's (1994) typology, scored differently on the 3 factors in ways consistent with theory. Therefore, the PAVE shows promise as a reliable and valid tool to help to understand the context and function of intimate partner violence.

1 February 2015 in Journal of Consulting and Clinical Psychology
Verified
Journal Article
Closed access
CKColton L. Keo-Meier
Colton L. Keo-Meier
LHLevi I. Herman
Levi I. Herman
SRSari L. Reisner
Sari L. Reisner
SPSeth T. Pardo
Seth T. Pardo
CSCarla Sharp
Carla Sharp
JBJULIA CAROLINE BABCOCK
JULIA CAROLINE BABCOCK
Most transgender men desire to receive testosterone treatment in order to masculinize their bodies. In this study, we aimed to investigate the short-term effects of testosterone treatment on psychological functioning in transgender men. This is the 1st controlled prospective follow-up study to examine such effects. We examined a sample of transgender men (n = 48) and nontransgender male (n = 53) and female (n = 62) matched controls (mean age = 26.6 years; 74% White). We asked participants to complete the Minnesota Multiphasic Personality Inventory (2nd ed., or MMPI-2; Butcher, Graham, Tellegen, Dahlstrom, & Kaemmer, 2001) to assess psychological functioning at baseline and at the acute posttreatment follow-up (3 months after testosterone initiation). Regression models tested (a) Gender × Time interaction effects comparing divergent mean response profiles across measurements by gender identity; (b) changes in psychological functioning scores for acute postintervention measurements, adjusting for baseline measures, comparing transgender men with their matched nontransgender male and female controls and adjusting for baseline scores; and (c) changes in meeting clinical psychopathological thresholds. Statistically significant changes in MMPI-2 scale scores were found at 3-month follow-up after initiating testosterone treatment relative to baseline for transgender men compared with female controls (female template): reductions in Hypochondria (p < .05), Depression (p < .05), Hysteria (p < .05), and Paranoia (p < .01); and increases in Masculinity-Femininity scores (p < .01). Gender × Time interaction effects were found for Hysteria (p < .05) and Paranoia (p < .01) relative to female controls (female template) and for Hypochondria (p < .05), Depression (p < .01), Hysteria (p < .01), Psychopathic Deviate (p < .05), Paranoia (p < .01), Psychasthenia (p < .01), and Schizophrenia (p < .01) compared with male controls (male template). In addition, the proportion of transgender men presenting with co-occurring psychopathology significantly decreased from baseline compared with 3-month follow-up relative to controls (p < .05). Findings suggest that testosterone treatment resulted in increased levels of psychological functioning on multiple domains in transgender men relative to nontransgender controls. These findings differed in comparisons of transgender men with female controls using the female template and with male controls using the male template. No iatrogenic effects of testosterone were found. These findings suggest a direct positive effect of 3 months of testosterone treatment on psychological functioning in transgender men.